tiprankstipranks
Trending News
More News >
Mydecine Innovations Group, Inc. (TSE:MYCO)
:MYCO
Advertisement

Mydecine Innovations Group (MYCO) Price & Analysis

Compare
97 Followers

MYCO Stock Chart & Stats


Mydecine Innovations Group News

MYCO FAQ

What was Mydecine Innovations Group, Inc.’s price range in the past 12 months?
Mydecine Innovations Group, Inc. lowest stock price was <C$0.01 and its highest was C$0.01 in the past 12 months.
    What is Mydecine Innovations Group, Inc.’s market cap?
    Mydecine Innovations Group, Inc.’s market cap is C$617.55K.
      When is Mydecine Innovations Group, Inc.’s upcoming earnings report date?
      Mydecine Innovations Group, Inc.’s upcoming earnings report date is Nov 18, 2025 which is in 104 days.
        How were Mydecine Innovations Group, Inc.’s earnings last quarter?
        Currently, no data Available
        Is Mydecine Innovations Group, Inc. overvalued?
        According to Wall Street analysts Mydecine Innovations Group, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Mydecine Innovations Group, Inc. pay dividends?
          Mydecine Innovations Group, Inc. does not currently pay dividends.
          What is Mydecine Innovations Group, Inc.’s EPS estimate?
          Mydecine Innovations Group, Inc.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Mydecine Innovations Group, Inc. have?
          Mydecine Innovations Group, Inc. has 61,755,398 shares outstanding.
            What happened to Mydecine Innovations Group, Inc.’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Mydecine Innovations Group, Inc.?
            Currently, no hedge funds are holding shares in TSE:MYCO

            Company Description

            Mydecine Innovations Group, Inc.

            Mydecine Innovations Group Inc is a biopharma and life sciences company. It is committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use. Reinforcing Mydecine's commitment to mental health solutions is underpinned by the company's three main focuses: Clinical Trials focusing on Veterans, EMS, and First Responders with a PTSD indication; Research and Development building a robust portfolio of intellectual property around drug discovery and unique delivery mechanisms with relevant use patents and future patent applications and Modern technology utilizing for better clinical trial management and mental health wellbeing.

            Mydecine Innovations Group (MYCO) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            Love Pharma Inc
            NeutriSci International
            Global Health Clinics
            Lumiera Health Inc
            NAVCO Pharmaceuticals Inc

            Ownership Overview

            <0.01%100.00%
            Insiders
            Mutual Funds
            <0.01% Other Institutional Investors
            100.00% Public Companies and
            Individual Investors

            Options Prices

            Currently, No data available
            ---
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis